Precision cancer monitoring using a novel, fully integrated, microfluidic array partitioning digital PCR platform.
Ontology highlight
ABSTRACT: A novel digital PCR (dPCR) platform combining off-the-shelf reagents, a micro-molded plastic microfluidic consumable with a fully integrated single dPCR instrument was developed to address the needs for routine clinical diagnostics. This new platform offers a simplified workflow that enables: rapid time-to-answer; low potential for cross contamination; minimal sample waste; all within a single integrated instrument. Here we showcase the capability of this fully integrated platform to detect and quantify non-small cell lung carcinoma (NSCLC) rare genetic mutants (EGFR T790M) with precision cell-free DNA (cfDNA) standards. Next, we validated the platform with an established chronic myeloid leukemia (CML) fusion gene (BCR-ABL1) assay down to 0.01% mutant allele frequency to highlight the plat
SUBMITTER: Dueck ME
PROVIDER: S-EPMC6925289 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA